Dow Up 0.48% Nasdaq Up 0.43%

Brainstorm Cell Therapeutics Inc. (BCLI)

-OTC BB
0.30 Down 0.00(0.17%) Aug 19, 3:57PM EDT
Prev Close:0.30
Open:0.30
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:-0.22
Next Earnings Date:N/A
Day's Range:0.30 - 0.30
52wk Range:0.10 - 0.38
Volume:369,263
Avg Vol (3m):1,204,630
Market Cap:66.89M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BCLI

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback